WO2000014119A3 - Bifunctional antibodies and their use in targeting anti-tumour agents - Google Patents
Bifunctional antibodies and their use in targeting anti-tumour agents Download PDFInfo
- Publication number
- WO2000014119A3 WO2000014119A3 PCT/GB1999/002938 GB9902938W WO0014119A3 WO 2000014119 A3 WO2000014119 A3 WO 2000014119A3 GB 9902938 W GB9902938 W GB 9902938W WO 0014119 A3 WO0014119 A3 WO 0014119A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bifunctional antibodies
- tumour agents
- targeting anti
- affinity
- antibody
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99943138A EP1107995A2 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
BR9913429-2A BR9913429A (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting antitumor agents |
EA200100311A EA200100311A1 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their application for targeted delivery of antitumor agents |
MXPA01002349A MXPA01002349A (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents. |
CA002341753A CA2341753A1 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
PL99346861A PL346861A1 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
IL14152499A IL141524A0 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumor agents |
AU56412/99A AU5641299A (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
JP2000568876A JP2002524470A (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeted antitumor agents |
KR1020017002437A KR20010072988A (en) | 1998-09-04 | 1999-09-06 | Bifunctional Antibodies and Their Use In Targeting Anti-tumour Agents |
HU0104091A HUP0104091A2 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
BG105293A BG105293A (en) | 1998-09-04 | 2001-02-26 | Bifunctional antibodies and their use in targeting anti-tumour agents |
NO20011102A NO20011102L (en) | 1998-09-04 | 2001-03-02 | Bifunctional antibodies and their use in targeting anti-tumor agents |
HR20010154A HRP20010154A2 (en) | 1998-09-04 | 2001-03-02 | Bifunctional antibodies and their use in targeting anti-tumour agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9819411.1 | 1998-09-04 | ||
GBGB9819411.1A GB9819411D0 (en) | 1998-09-04 | 1998-09-04 | Antibodies |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09786013 A-371-Of-International | 2001-04-24 | ||
US10/445,132 Continuation US20030215387A1 (en) | 1998-09-04 | 2003-05-22 | Bifunctional antibodies and their use in targeting anti-tumour agents |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000014119A2 WO2000014119A2 (en) | 2000-03-16 |
WO2000014119A3 true WO2000014119A3 (en) | 2000-11-30 |
Family
ID=10838416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/002938 WO2000014119A2 (en) | 1998-09-04 | 1999-09-06 | Bifunctional antibodies and their use in targeting anti-tumour agents |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1107995A2 (en) |
JP (1) | JP2002524470A (en) |
KR (1) | KR20010072988A (en) |
CN (1) | CN1315967A (en) |
AU (1) | AU5641299A (en) |
BG (1) | BG105293A (en) |
BR (1) | BR9913429A (en) |
CA (1) | CA2341753A1 (en) |
EA (1) | EA200100311A1 (en) |
GB (1) | GB9819411D0 (en) |
HR (1) | HRP20010154A2 (en) |
HU (1) | HUP0104091A2 (en) |
ID (1) | ID28873A (en) |
IL (1) | IL141524A0 (en) |
MX (1) | MXPA01002349A (en) |
NO (1) | NO20011102L (en) |
PL (1) | PL346861A1 (en) |
TR (2) | TR200103405T2 (en) |
WO (1) | WO2000014119A2 (en) |
ZA (1) | ZA200101574B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117442717A (en) | 2018-06-01 | 2024-01-26 | 大有华夏生物医药集团有限公司 | Compositions for treating diseases or conditions and uses thereof |
EP3826673A4 (en) * | 2018-07-26 | 2022-03-09 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and methods for imaging |
CN110811820B (en) * | 2019-12-11 | 2022-07-12 | 江西华晨医疗设备有限公司 | Straight rod type flushing and suction electrocoagulation cutter |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
EP0369566A2 (en) * | 1988-11-17 | 1990-05-23 | Hybritech Incorporated | Bifunctional chimeric antibodies |
WO1991009134A1 (en) * | 1989-12-15 | 1991-06-27 | Takeda Chemical Industries, Ltd. | Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics |
US5217713A (en) * | 1988-12-27 | 1993-06-08 | Takeda Chemical Industries, Ltd. | Cytotoxic bispecific monoclonal antibody, its production and use |
JPH05184383A (en) * | 1990-06-19 | 1993-07-27 | Dainabotsuto Kk | Bispecific antibody |
WO1998038513A1 (en) * | 1997-02-26 | 1998-09-03 | Khaw Ban An | Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
-
1998
- 1998-09-04 GB GBGB9819411.1A patent/GB9819411D0/en not_active Ceased
-
1999
- 1999-09-06 WO PCT/GB1999/002938 patent/WO2000014119A2/en not_active Application Discontinuation
- 1999-09-06 BR BR9913429-2A patent/BR9913429A/en not_active IP Right Cessation
- 1999-09-06 ID IDW20010752A patent/ID28873A/en unknown
- 1999-09-06 EP EP99943138A patent/EP1107995A2/en not_active Withdrawn
- 1999-09-06 TR TR2001/03405T patent/TR200103405T2/en unknown
- 1999-09-06 HU HU0104091A patent/HUP0104091A2/en unknown
- 1999-09-06 MX MXPA01002349A patent/MXPA01002349A/en not_active Application Discontinuation
- 1999-09-06 EA EA200100311A patent/EA200100311A1/en unknown
- 1999-09-06 IL IL14152499A patent/IL141524A0/en unknown
- 1999-09-06 JP JP2000568876A patent/JP2002524470A/en active Pending
- 1999-09-06 AU AU56412/99A patent/AU5641299A/en not_active Abandoned
- 1999-09-06 PL PL99346861A patent/PL346861A1/en not_active Application Discontinuation
- 1999-09-06 CA CA002341753A patent/CA2341753A1/en not_active Abandoned
- 1999-09-06 KR KR1020017002437A patent/KR20010072988A/en not_active Application Discontinuation
- 1999-09-06 TR TR2001/00651T patent/TR200100651T2/en unknown
- 1999-09-06 CN CN99810368A patent/CN1315967A/en active Pending
-
2001
- 2001-02-26 ZA ZA200101574A patent/ZA200101574B/en unknown
- 2001-02-26 BG BG105293A patent/BG105293A/en unknown
- 2001-03-02 NO NO20011102A patent/NO20011102L/en unknown
- 2001-03-02 HR HR20010154A patent/HRP20010154A2/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
EP0369566A2 (en) * | 1988-11-17 | 1990-05-23 | Hybritech Incorporated | Bifunctional chimeric antibodies |
US5217713A (en) * | 1988-12-27 | 1993-06-08 | Takeda Chemical Industries, Ltd. | Cytotoxic bispecific monoclonal antibody, its production and use |
WO1991009134A1 (en) * | 1989-12-15 | 1991-06-27 | Takeda Chemical Industries, Ltd. | Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics |
JPH05184383A (en) * | 1990-06-19 | 1993-07-27 | Dainabotsuto Kk | Bispecific antibody |
WO1998038513A1 (en) * | 1997-02-26 | 1998-09-03 | Khaw Ban An | Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
Non-Patent Citations (4)
Title |
---|
BRITISH JOURNAL OF CANCER, vol. 67 367, no. 3, 1993, UK, pages 436 - 440, XP002901232, ISSN: 0007-0920 * |
DATABASE DIALOG [online] BRUYNCK A ET AL: "Characterisation of a humanised bispecific monoclonal antibody for cancer therapy", XP002900882, retrieved from EMBASE accession no. 1993077634 * |
DATABASE WPI Section Ch Week 199334, Derwent World Patents Index; Class B04, AN 1993-269042, XP002901224 * |
HUI ZHU ET AL: "Tumor Pretargeting for Radioimmunodetection and Radioimmunotherapy", J NUCL MED, vol. 39, no. 1, January 1998 (1998-01-01), pages 65 - 76, XP002901225 * |
Also Published As
Publication number | Publication date |
---|---|
HUP0104091A2 (en) | 2002-03-28 |
HRP20010154A2 (en) | 2002-02-28 |
NO20011102L (en) | 2001-03-05 |
IL141524A0 (en) | 2002-03-10 |
AU5641299A (en) | 2000-03-27 |
BR9913429A (en) | 2001-09-25 |
BG105293A (en) | 2001-12-29 |
JP2002524470A (en) | 2002-08-06 |
CN1315967A (en) | 2001-10-03 |
GB9819411D0 (en) | 1998-10-28 |
WO2000014119A2 (en) | 2000-03-16 |
TR200100651T2 (en) | 2001-07-23 |
ID28873A (en) | 2001-07-12 |
EP1107995A2 (en) | 2001-06-20 |
NO20011102D0 (en) | 2001-03-02 |
PL346861A1 (en) | 2002-03-11 |
KR20010072988A (en) | 2001-07-31 |
EA200100311A1 (en) | 2001-08-27 |
MXPA01002349A (en) | 2003-10-15 |
TR200103405T2 (en) | 2002-06-21 |
CA2341753A1 (en) | 2000-03-16 |
ZA200101574B (en) | 2002-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004018000A3 (en) | Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents | |
ATE383430T1 (en) | RECOMBINANT ANTIBODIES AND IMMUNE CONJUGATES TARGETED AT CD22-BEARING CELLS AND TUMORS | |
CA2318576A1 (en) | Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use | |
AU5303700A (en) | Immunoconjugates having high binding affinity | |
ATE365562T1 (en) | TARGETED COMBINATION IMMUNOTHERAPY FOR CANCER | |
WO2001082899A3 (en) | Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites | |
WO2004073656A3 (en) | Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders | |
WO2003072754A3 (en) | Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use | |
WO2001082975A3 (en) | Membrane-permeant peptide complexes for medical imaging | |
ATE296105T1 (en) | IMININE-FORMING POLYSACCHARIDES, THEIR PREPARATION AND USE AS ADDITIVES AND IMMUNO-STIMULANT AGENTS | |
WO2003083041A8 (en) | Cripto-specific antibodies | |
EP0505357A4 (en) | ||
AU9312198A (en) | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer | |
WO2000018439A3 (en) | Use of neoangiogenesis markers for diagnosing and treating tumours by therapy | |
RU92016354A (en) | COMPOSITION, METHODS OF TREATMENT, METHOD OF PREVENTION OF RECURRENCE, METHOD OF ENHANCING CYTOTOXIC ACTIVITY OF IMMUNOTOXIN, METHOD OF ENHANCING CYTOTOXIC ACTION OF CONJUGATE | |
DE60113445D1 (en) | SUBSTANCES WITH BRANCHED LINKERMOLEKÜLEN | |
WO2000013712A3 (en) | Methods and compositions for the prevention or treatment of cancer | |
WO2000053231A3 (en) | Fatty acid-anticancer conjugates and uses thereof | |
ZA929575B (en) | Bicyclopolyazamacrocyclocarboxyclic acid complexes,their conjugates,processes for their preparation,and use as contrast agents | |
HUP0100350A3 (en) | Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use | |
WO2000014119A3 (en) | Bifunctional antibodies and their use in targeting anti-tumour agents | |
WO1997026918A3 (en) | Ligand directed enzyme prodrug therapy | |
ATE249243T1 (en) | BIOTINYLATED ANTIBODIES WITH REDUCED POSITIVE NET LOAD AND TOXIN, DRUG OR CHELATE | |
WO2002066075A3 (en) | Biotin-derivatives and their conjugates with chelating agents | |
EP1520588A3 (en) | Uses of antibodies to aminophospholipids for cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99810368.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999943138 Country of ref document: EP Ref document number: IN/PCT/2001/00156/DE Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 141524 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-657 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 508574 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 1999 105293 Country of ref document: BG Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/01574 Country of ref document: ZA Ref document number: 1020017002437 Country of ref document: KR Ref document number: 200101574 Country of ref document: ZA Ref document number: P-151/01 Country of ref document: YU |
|
ENP | Entry into the national phase |
Ref document number: 2341753 Country of ref document: CA Ref document number: 2341753 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/00651 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/002349 Country of ref document: MX Ref document number: P20010154A Country of ref document: HR |
|
ENP | Entry into the national phase |
Ref document number: 2000 568876 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 56412/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 20010258 Country of ref document: UZ Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200100311 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09786013 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999943138 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-657 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017002437 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/03405 Country of ref document: TR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999943138 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017002437 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-657 Country of ref document: CZ |